Betrixaban Medication: Uses, Dosage, and Side Effects Explained

Summary of Key Points

Betrixaban is an anticoagulant medication used to prevent blood clots in conditions such as deep vein thrombosis (DVT) and pulmonary embolism (PE). It works by inhibiting specific clotting factors, thereby reducing the risk of dangerous clots. Betrixaban is typically prescribed for patients at risk of venous thromboembolism (VTE) and related conditions. Always consult your healthcare provider before starting or adjusting your Betrixaban dosage.

Names of Medication

US Brand Name: Bevyxxa (Betrixaban)

The “generic name” refers to the active ingredient in the medication, which remains consistent across all brands. The generic name is listed in parentheses.

Pharmacologic Category

Factor Xa Inhibitor

Anticoagulant

Betrixaban Dosage

Betrixaban is used to treat and prevent conditions related to blood clots. Dosage may vary depending on the condition being treated. Always follow your healthcare provider’s instructions and consult them before making any changes to your medication. If needed, you can schedule a telemedicine visit with us today.

Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Prevention

The typical dose of Betrixaban is 160 mg on the first day, followed by 80 mg once daily for 35 to 42 days.

Atrial Fibrillation

Betrixaban is not typically indicated for atrial fibrillation. Consult your healthcare provider for alternative treatments.

Venous Thromboembolism (VTE)

For patients at risk of VTE, the recommended dose is 160 mg on the first day, followed by 80 mg once daily for 35 to 42 days.

Stroke Prevention

Betrixaban is not commonly used for stroke prevention. Discuss other options with your healthcare provider.

Myocardial Infarction (Heart Attack)

Betrixaban is not indicated for heart attack prevention. Consult your healthcare provider for appropriate medications.

Thrombosis

For general thrombosis prevention, the dose is 160 mg on day one, followed by 80 mg daily for 35 to 42 days.

Post-Operative Thrombosis Prevention

The recommended dose of Betrixaban for post-operative thrombosis prevention is 160 mg on the first day, followed by 80 mg once daily for 35 to 42 days.

Coronary Artery Disease (CAD) and Peripheral Artery Disease (PAD)

Betrixaban is not typically used for CAD or PAD. Please consult your healthcare provider for alternative treatments.

Dosage Forms and Strengths

Betrixaban is available in capsule form with the following strengths:

1. 40 mg
2. 80 mg

Administration Instructions

Betrixaban should be taken with food to improve absorption. Swallow the capsule whole with water. Do not crush, chew, or open the capsule. If you miss a dose, take it as soon as you remember, but do not take two doses at once. Always follow your healthcare provider’s instructions closely. If you have any questions, schedule a telemedicine visit with us for further guidance.

Betrixaban Side Effects and Adverse Reactions

Like all medications, Betrixaban may cause side effects. It’s important to be aware of these and consult your healthcare provider if you experience any. If you need immediate medical advice, you can reach out to one of our providers through telemedicine.

Common Side Effects

Bleeding: Betrixaban increases the risk of bleeding, which may occur in the gums, nose, or gastrointestinal tract. Notify your doctor if you experience unusual bleeding.

Bruising: You may notice more frequent or severe bruising while taking Betrixaban.

Less Common Side Effects

Dizziness: Some patients report feeling lightheaded or dizzy. If this occurs, avoid driving or operating heavy machinery.

Headache: Mild to moderate headaches may occur but are generally manageable.

Rare but Serious Side Effects

Severe Bleeding: In rare cases, Betrixaban can cause life-threatening bleeding. Seek immediate medical attention if you experience heavy bleeding, black or tarry stools, or coughing up blood.

Allergic Reactions: Although rare, some patients may experience allergic reactions such as rash, itching, or swelling. If you notice any signs of an allergic reaction, contact your healthcare provider immediately.

Contraindications for Betrixaban

A contraindication is a specific situation or condition where a medication should not be used because it may cause harm. It’s important to understand these situations to avoid serious side effects or complications. If you have any of the following conditions, Betrixaban may not be safe for you.

Active Bleeding

Betrixaban is an anticoagulant, which helps prevent blood clots. If you are already experiencing active bleeding, taking Betrixaban could worsen the bleeding.

Severe Liver Disease

The liver processes many medications, including Betrixaban. If you have severe liver disease, your body may not process the drug properly, increasing the risk of bleeding or other complications.

Allergy to Betrixaban

If you have had an allergic reaction to Betrixaban or any of its ingredients in the past, you should not take this medication, as it could cause a serious allergic reaction, including difficulty breathing or swelling.

Mechanical Heart Valves

Patients with mechanical heart valves should not take Betrixaban because it has not been proven effective in preventing blood clots in these patients. Other anticoagulants may be more appropriate.

Betrixaban Drug Interactions

Betrixaban can interact with other medications, increasing the risk of bleeding or reducing its effectiveness. Be sure to tell your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. The following medications may interact with Betrixaban:

Ketoconazole (Nizoral)

This antifungal medication can increase Betrixaban levels in your blood, raising the risk of bleeding.

Amiodarone (Pacerone)

This heart rhythm medication can enhance the effects of Betrixaban, potentially increasing the risk of bleeding.

Verapamil (Calan, Verelan)

This blood pressure medication may also increase Betrixaban levels, heightening the risk of bleeding.

Rifampin (Rifadin)

This antibiotic can reduce Betrixaban’s effectiveness by lowering its levels in your blood, which may reduce its ability to prevent blood clots.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Medications like ibuprofen (Advil, Motrin) and naproxen (Aleve) can increase the risk of bleeding when taken with Betrixaban.

Betrixaban in Pregnancy

Is it safe to take Betrixaban when pregnant?

The safety of Betrixaban during pregnancy has not been well established. There is limited data on its use in pregnant women, and animal studies suggest there may be potential risks. If you are pregnant or planning to become pregnant, it is important to discuss the risks and benefits of taking Betrixaban with your healthcare provider. They will help you carefully weigh the benefits of preventing blood clots against any possible risks to your baby. For immediate guidance, our telemedicine providers are available to assist you.

Betrixaban while Breastfeeding

Is it safe to take Betrixaban while breastfeeding?

Currently, there is no information available on whether Betrixaban passes into breast milk. Due to the potential for serious side effects in a nursing infant, it is generally recommended that breastfeeding women either avoid taking Betrixaban or discontinue breastfeeding while using the medication. Consult your healthcare provider to determine the best course of action for both you and your baby.

Estimated Cost of Betrixaban Medication

The estimated cost of a 30-day supply of Betrixaban without insurance can vary depending on the pharmacy and location. However, with a GoodRx coupon, the price typically ranges from $300 to $450 for a 30-day supply. Be sure to check with your pharmacy or use a discount service like GoodRx to find the most affordable option.

Possible Alternatives to Betrixaban

If Betrixaban is not suitable for you, or if you’re exploring alternative treatments, other medications and lifestyle changes may help manage your condition. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are available to discuss these options with you.

Deep Vein Thrombosis (DVT)

Alternatives to Betrixaban for preventing or treating DVT include anticoagulants such as warfarin (Coumadin), rivaroxaban (Xarelto), or apixaban (Eliquis). Additionally, wearing compression stockings and engaging in regular physical activity can improve blood flow and reduce the risk of clots.

Pulmonary Embolism (PE)

Similar to DVT, anticoagulants like warfarin, rivaroxaban, or apixaban are commonly used to treat PE. In some cases, thrombolytic therapy (clot-busting drugs) may be necessary to dissolve the clot.

Atrial Fibrillation (AFib)

For patients with AFib, anticoagulants such as warfarin, apixaban, or dabigatran (Pradaxa) are often prescribed to reduce the risk of stroke. Lifestyle changes, including managing high blood pressure and quitting smoking, can also help lower your risk.

Venous Thromboembolism (VTE)

Anticoagulants like rivaroxaban, apixaban, or dabigatran are frequently used to treat VTE. Regular exercise and maintaining a healthy weight can further reduce your risk of future clots.

Stroke

In addition to anticoagulants, lifestyle changes such as controlling high blood pressure, following a heart-healthy diet, and quitting smoking can significantly reduce the risk of stroke.

Myocardial Infarction (Heart Attack)

Medications like aspirin, beta-blockers, and statins are often prescribed to prevent future heart attacks. Lifestyle modifications, including a heart-healthy diet, regular exercise, and quitting smoking, are also crucial for long-term heart health.

Thrombosis

Depending on the location and cause of the thrombosis, anticoagulants such as warfarin, rivaroxaban, or apixaban may be recommended. Regular physical activity and maintaining a balanced diet can also help lower your risk.

Post-Operative Thrombosis

After surgery, anticoagulants like enoxaparin (Lovenox) or rivaroxaban may be prescribed to prevent blood clots. Early mobilization and the use of compression stockings can also help reduce the risk of post-operative thrombosis.

Coronary Artery Disease (CAD)

Medications such as aspirin, statins, and beta-blockers are commonly used to manage CAD. Lifestyle changes, including quitting smoking, eating a heart-healthy diet, and exercising regularly, can also play a significant role in managing the condition.

Peripheral Artery Disease (PAD)

In addition to medications like aspirin or clopidogrel (Plavix), lifestyle changes such as regular exercise, quitting smoking, and managing high blood pressure can help improve symptoms and reduce the risk of complications.

Recent Updates on Betrixaban Research

Recent studies have focused on the long-term safety and effectiveness of Betrixaban, particularly in patients at risk for venous thromboembolism (VTE) and those with a history of prolonged immobility. Ongoing research is also exploring the potential benefits of Betrixaban in preventing blood clots in cancer patients, who are at higher risk for clotting complications. Currently, Betrixaban remains a valuable option for preventing VTE in patients hospitalized for acute medical illnesses. Stay informed about new findings, as research in this area continues to evolve.

For more personalized advice on Betrixaban or other treatment options, consider scheduling a telemedicine appointment with one of our providers today.

James Kingsley

Learn More